Arrowhead Research reported $8.62B in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agios Pharmaceuticals AGIO:US $ 3.39B 211.72M
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Anika Therapeutics ANIK:US $ 623M 38.49M
Arena Pharmaceuticals ARNA:US $ 4.16B 41.38M
Arrowhead Research ARWR:US $ 8.62B 1.74B
Bluebird Bio BLUE:US $ 2.16B 132.67M
Cerulean Pharma CERU:US $ 93.27M 13.31M
Dicerna Pharmaceuticals DRNA:US $ 2.87B 918.39M
Heron Therapeutics HRTX:US $ 1.58B 98.85M
Intercept Pharmaceuticals ICPT:US $ 663.03M 98.97M
Ligand Pharmaceuticals LGND:US $ 2.18B 347.98M
Merk MRK:US $ 196918.18M 1780.24M
Mirati Therapeutics MRTX:US $ 8.31B 483.81M
Moderna Inc MRNA:US $ 94.35B 41.95B
Nektar Therapeutics NKTR:US $ 3.13B 515.22M
Novartis NOVN:VX 208.02B 8.76B
Opko Health OPK:US $ 2.71B 160.32M
Sarepta Therapeutics SRPT:US $ 6.2B 282.45M
Spectrum Pharmaceuticals SPPI:US $ 615.4M 114.24M
Tg Therapeutics TGTX:US $ 5.51B 1.27B
Ultragenyx Pharmaceutical RARE:US $ 6.43B 1.19B
Vertex Pharmaceuticals VRTX:US $ 52.2B 3.42B
Xencor XNCR:US $ 2.01B 489.02M
YTE INCY:US $ 18.5B 632.77M